ArticleAnnals of surgical oncology2025

Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors.

Luis C Borbon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.